- Joined
- Sep 6, 2006
- Messages
- 66
- Reaction score
- 0
I was wondering if anyone knows (or has an opinion) about Ameripath's GI fellowship. - Thanks,
I was wondering if anyone knows (or has an opinion) about Ameripath's GI fellowship. - Thanks,
I was wondering if anyone knows (or has an opinion) about Ameripath's GI fellowship. - Thanks,
I think a better question is would you be restricted for working Ameripath for the rest of your life? How do private practice groups view Ameripath trained candidates? Can you jump into a private practice gig after the fellowship if you had to (more options other than just working for Ameripath the rest of your life)? What is the job security if you had to work Ameripath the rest of your life (ie. what if things change in the future and they dont need you anymore and boot you...how easy would it be to hook up with a private practice group after years of working for Ameripath?
These are questions Id like the answers to as well.
Any ideas of how the Ameripath fellowship compares to the other corporate GI fellowships i.e. Caris Diagnostics or GI Pathology Partners. Are these other fellowships similar in that they only set you up to work at there lab or is there chance to move into private practice?
Any ideas of how the Ameripath fellowship compares to the other corporate GI fellowships i.e. Caris Diagnostics or GI Pathology Partners. Are these other fellowships similar in that they only set you up to work at there lab or is there chance to move into private practice?
Regarding the Caris GI pathology fellowship, it is actually more well-rounded than most people would think.
Caris gets a decent amount of general surgical pathology cases(breast, prostate, bladder, soft tissue, you name it), which the fellow is able to as much or as little as they want to.
6 weeks of the fellowship is spent with a hospital-based private practice group in the Dallas area which has very active pancreatic surgeons and liver transplant service...... all of which the fellow is integrated into.
2 weeks of the fellowship can be spent at the VA hospital in Dallas, spending time in the endoscopy suites
Caris also has a relationship with UT-Southwestern and the fellow spends 1/2 day each week their attending the clinical GI and Liver conferences, as well as any interesting conferences the UTSW pathology dept. puts on.
So at least regarding Caris............the GI fellowship is much more than just signing out mucosal biopsies all day.
Hope the info helps.
They offer kickbacks (free stuff) to medical groups to get their business. In business parlance, they "work with the group to identify cost-saving methods and opportunities to increase income." However, some of this is just venting because I don't like what they do and it benefits their shareholders and the groups they serve almost solely at the expense of pathologists (both their own and the ones whose business they steal). Other big labs are similar but Caris' tentacles are somewhat larger. However, I must admit I am not completely informed about this and they have not really impacted our group terribly.
Isnt this illegal? I've heard of it...so why can't they be prosecuted for this?
Here's a post from Oppenheimer's (OURlab fame) blog years back:
EMR donations: Who is paying the money, where is it from?
Commercial labs, including my own, are now offering six-figure "donations" of EMR (Electronic Medical Record) software, maintenance, and training to clinicians. While this is not illegal, it does bring to bear the possiblity of conflict of interest.
Just where is the money coming from ??? From patients and insurance companies of course. And unneccessary medical testing (triple immunohistochemical stains, working up multiple prostate cores when only working up the most severe is required, routine UroVysion FISH analysis on non-smokers with microhematuria) provides the excess revenue which can be skimmed off the bottom line to support these donations.
Clinicians should know that accepting EMR docations could incentivze laboratories to run unnecessary tests ultimately paid for by their patients co-pay and deductibles. Labs that do not have to make a profit for external investors have less of an incentive to overutilize lab resources.
These guys are ripping patients and insurance companies off.